Switzerland· 63175005
APO-go
A apomorphine product containing apomorphini hydrochloridum hemihydricum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Apomorphine is registered in 10 of 19 countries.
Countries holding a registration under ATC N04BC07 (apomorphine), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 7 of them publish a price we can compare per daily dose
Apomorphine · ATC N04BC07
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of apomorphine costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- Switzerland: $18.87 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Apomorphine · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$18.87
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- apomorphini hydrochloridum hemihydricum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- N04BC07
- ATC class
- Apomorphine
- Defined daily dose
- 20 mg, P
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin76806317500503 ml 5 StkCHF 168.2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
226 interactions on record for apomorphine.
Graded by severity as the source publishes them — 41 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Apomorphine · interactions on record
226 records
- 41 severe
- 182 moderate
- 2 minor
- 1 info
Most severe, free to view
- PapaverineA03AD01severe
- AlosetronA03AE01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Apomorphine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBRITAJECT PENSTADA Arzneimittel AG, Bad Vilbel
- SwedenAPO-go PEN 10 mg/ml Injektionsvätska, lösningSTADA Arzneimittel AG
- SpainAPO-GO PEN 10 mg/ml SOLUCION INYECTABLEStada Arzneimittel Ag
- BelgiumAPO-GO-PEN 10 mg/mlEG
- NorwayBritajectStada Arzneimittel AG
- PolandDaceptonEver Neuro Pharma GmbH
- United KingdomAPO-go 20mg/2ml solution for injection ampoulesBritannia Pharmaceuticals Ltd
- FinlandApogo PenParanova Oy
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Apo-Go, Apo-Go Ampullen
- Belgium · Apo-Go ®-Cartridge, Apo-Go-Pen
- Bulgaria · Dacepton, Апо-Гo Пнс
- Cyprus · Apo-Go Pfs, Apo-Go Συσκευή Τύπου Πένασ
- Czechia · Britaject, Britaject Pen
- Germany · Apo-Go, Apo-Go Ampullen
- Denmark · Apo-Go Pen, Apo-Go Pod
- Estonia · Apo-Go, Dacepton
- Spain · Apo-Go, Apo-Go Pen
- Finland · Apogo Pen, Dacepton
- France · Apokinon, Apomorphine Biogaran
- United Kingdom (Northern Ireland) · Apo-Go Ampoules, Apo-Go Pen
- Greece · Apo-Go Pfs, Apo-Go Pod
- Croatia · Dacepton
- Hungary · Dacepton
- Ireland · Apo-Go Ampoules, Apo-Go Pen
- Italy · Apofin, Dacepton
- Lithuania · Britaject, Dacepton
- Luxembourg · Apo-Go Ampoules, Apo-Go Pen
- Latvia · Apo-Go, Apo-Go Pen
- Malta · Apo-Go Pen, Apo-Go Pfs
- Netherlands · Apo-Go, Apo-Go Ampullen
- Norway · Apomorfin Pharmswed, Britaject
- Poland · Dacepton
- Portugal · Apo-Go, Apo-Go Pen
- Romania · Apo-Go
- Sweden · Apo-Go, Apo-Go För Pod
- Slovenia · Apo-Go, Dacepton
- Slovakia · Dacepton
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ef74b4f2-45c3-48ae-81be-7c58231d91d9 GET /v1/drugs/ef74b4f2-45c3-48ae-81be-7c58231d91d9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "apomorphini hydrochloridum hemihydricum 30 mg",
"valid_from": "2023-02-01",
"limitations": "[{\"description\":\"Nach Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes zur subkutanen Bedarfsbehandlung von Parkinson-Patienten mit motorischen On-Off-Fluktuationen zusätzlich zur oralen Therapie, um die tägliche Off-Dauer zu verkürzen.<br>\\nDie Patienten müssen in der Lage sein, den Beginn ihrer Off-Symptome selber zu erkennen und die Selbstverabreichung mit dem Pen vorzunehmen bzw. eine Betreuungsperson zur Verfügung haben, die dazu in der Lage ist.<br>\\nDie Verordnung und die Überwachung der Therapie darf ausschliesslich durch einen in der Behandlung der Parkinson'schen Krankheit erfahrenen Facharzt der Neurologie erfolgen.<br>\\n<br>\\n\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2023-02-01\",\"validTo\":null}]",
"galenic_form": "Inj Lös 30 mg/3 ml Pen",
"therapeutic_area": null,
"sl_inclusion_date": "2020-02-01",
"self_retention_pct": 10
}See everything about apomorphine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.